Literature DB >> 9309711

Calpain-3 deficiency causes a mild muscular dystrophy in childhood.

H Topaloğlu1, P Dinçer, I Richard, Z Akçören, D Alehan, S Ozme, M Cağlar, A Karaduman, J A Urtizberea, J S Beckmann.   

Abstract

Among our 20 families with LGMD2, 10 were documented to have muscle-specific calcium-activated neutral protease 3 (calpain-3) deficiency. Consanguinity was present in all. The current ages of the index cases were between 12 and 23 years, and there were additional nine members affected. Clinically, the patients showed mild courses; none of the cases below age 30 lost autonomy so far. The dystrophy is mainly proximal and atrophic with calf enlargement and scapular wasting in some. In three cases walking was delayed. Creatine kinase levels were at least 10 times elevated. All obligate carriers had normal creatine kinase levels. Five families shared the same 551 delA frameshift mutation. In four of these families there was the same core haplotype, whereas one was distinct suggesting an independent origin. Calpain-3 deficiency in general is a mild muscular dystrophy during childhood.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309711     DOI: 10.1055/s-2007-973702

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

1.  A cross section of autosomal recessive limb-girdle muscular dystrophies in 38 families.

Authors:  P Dinçer; Z Akçören; E Demir; I Richard; O Sancak; G Kale; S Ozme; A Karaduman; E Tan; J A Urtizberea; J S Beckmann; H Topaloğlu
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

2.  Calpainopathy-a survey of mutations and polymorphisms.

Authors:  I Richard; C Roudaut; A Saenz; R Pogue; J E Grimbergen; L V Anderson; C Beley; A M Cobo; C de Diego; B Eymard; P Gallano; H B Ginjaar; A Lasa; C Pollitt; H Topaloglu; J A Urtizberea; M de Visser; A van der Kooi; K Bushby; E Bakker; A Lopez de Munain; M Fardeau; J S Beckmann
Journal:  Am J Hum Genet       Date:  1999-06       Impact factor: 11.025

3.  Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A.

Authors:  L V Anderson; K Davison; J A Moss; I Richard; M Fardeau; F M Tomé; C Hübner; A Lasa; J Colomer; J S Beckmann
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

4.  Calpain-3 mutations in Turkey.

Authors:  Burcu Balci; Stefania Aurino; Göknur Haliloglu; Beril Talim; Sevim Erdem; Zuhal Akcören; Ersin Tan; Melda Caglar; Isabelle Richard; Vincenzo Nigro; Haluk Topaloglu; Pervin Dincer
Journal:  Eur J Pediatr       Date:  2006-01-13       Impact factor: 3.183

5.  Mitochondrial dysfunction and consequences in calpain-3-deficient muscle.

Authors:  Vanessa E Jahnke; Jennifer M Peterson; Jack H Van Der Meulen; Jessica Boehler; Kitipong Uaesoontrachoon; Helen K Johnston; Aurelia Defour; Aditi Phadke; Qing Yu; Jyoti K Jaiswal; Kanneboyina Nagaraju
Journal:  Skelet Muscle       Date:  2020-12-11       Impact factor: 4.912

6.  Progression to Loss of Ambulation Among Patients with Autosomal Recessive Limb-girdle Muscular Dystrophy: A Systematic Review.

Authors:  Ivana F Audhya; Antoinette Cheung; Shelagh M Szabo; Emma Flint; Conrad C Weihl; Katherine L Gooch
Journal:  J Neuromuscul Dis       Date:  2022

7.  Mutations of CAPN3 in Korean patients with limb-girdle muscular dystrophy.

Authors:  Jin-Hong Shin; Hyang-Suk Kim; Chang-Hoon Lee; Cheol-Min Kim; Kyu-Hyun Park; Dae-Seong Kim
Journal:  J Korean Med Sci       Date:  2007-06       Impact factor: 2.153

Review 8.  Calcium Mechanisms in Limb-Girdle Muscular Dystrophy with CAPN3 Mutations.

Authors:  Jaione Lasa-Elgarresta; Laura Mosqueira-Martín; Neia Naldaiz-Gastesi; Amets Sáenz; Adolfo López de Munain; Ainara Vallejo-Illarramendi
Journal:  Int J Mol Sci       Date:  2019-09-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.